Literature DB >> 24686099

IgG kappa monoclonal gammopathy of undetermined significance presenting as acquired type III Von Willebrand syndrome.

Christin R Howard1, Tara L Lin, Mark T Cunningham, Brea C Lipe.   

Abstract

Acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder associated with hematoproliferative disorders, autoimmune conditions, neoplasia and cardiovascular disorders that often present a diagnostic challenge. Monoclonal gammopathy of undetermined significance (MGUS) is one of the most common causes of AVWS that typically presents later in life with mucocutaneous or postsurgical bleeding and multimers consistent with type I or II von Willebrand disease (VWD). Here, we present the case of a patient with a 32-year history of type III VWD that was ultimately found to be AVWS related to an IgG MGUS. In this case report, we highlight the diagnostic challenges of AVWS to ensure proper identification and potentially lifesaving treatment of this rare disorder.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24686099      PMCID: PMC4119490          DOI: 10.1097/MBC.0000000000000112

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  11 in total

Review 1.  Acquired von Willebrand syndrome: from pathophysiology to management.

Authors:  A Veyradier; C S Jenkins; E Fressinaud; D Meyer
Journal:  Thromb Haemost       Date:  2000-08       Impact factor: 5.249

Review 2.  Diagnosis of inherited von Willebrand disease: a clinical perspective.

Authors:  Augusto B Federici
Journal:  Semin Thromb Hemost       Date:  2006-09       Impact factor: 4.180

Review 3.  Von Willebrand disease.

Authors:  Andra H James
Journal:  Obstet Gynecol Surv       Date:  2006-02       Impact factor: 2.347

Review 4.  Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.

Authors:  J J Michiels; U Budde; M van der Planken; H H van Vliet; W Schroyens; Z Berneman
Journal:  Best Pract Res Clin Haematol       Date:  2001-06       Impact factor: 3.020

Review 5.  How I treat the acquired von Willebrand syndrome.

Authors:  Andreas Tiede; Jacob H Rand; Ulrich Budde; Arnold Ganser; Augusto B Federici
Journal:  Blood       Date:  2011-05-03       Impact factor: 22.113

Review 6.  Acquired von Willebrand disease.

Authors:  Shaji Kumar; Rajiv K Pruthi; William L Nichols
Journal:  Mayo Clin Proc       Date:  2002-02       Impact factor: 7.616

7.  Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study.

Authors:  A Tiede; J Priesack; S Werwitzke; K Bohlmann; B Oortwijn; P Lenting; R Eisert; A Ganser; U Budde
Journal:  J Thromb Haemost       Date:  2008-01-17       Impact factor: 5.824

Review 8.  von Willebrand factor to the rescue.

Authors:  Simon F De Meyer; Hans Deckmyn; Karen Vanhoorelbeke
Journal:  Blood       Date:  2009-03-24       Impact factor: 22.113

9.  Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel.

Authors:  Andra H James; Peter A Kouides; Rezan Abdul-Kadir; Mans Edlund; Augusto B Federici; Susan Halimeh; Pieter W Kamphuisen; Barbara A Konkle; Oscar Martínez-Perez; Claire McLintock; Flora Peyvandi; Rochelle Winikoff
Journal:  Am J Obstet Gynecol       Date:  2009-05-30       Impact factor: 8.661

10.  Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.

Authors:  A B Federici; F Stabile; G Castaman; M T Canciani; P M Mannucci
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

View more
  3 in total

1.  Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma.

Authors:  Zachary Wolfe; Bradley Lash
Journal:  Case Rep Hematol       Date:  2017-05-29

2.  Combination of acquired von Willebrand syndrome (AVWS) and Glanzmann thrombasthenia in monoclonal gammopathy of uncertain significance (MGUS), a case report.

Authors:  Elizabeth Sarah Mayne; Malcolm Tait; Barry Frank Jacobson; Evashin Pillay; Susan J Louw
Journal:  Thromb J       Date:  2018-11-26

Review 3.  Longitudinal extensive transverse myelitis with an abnormal uFLC ratio in a pediatric patient: Case report and literature review.

Authors:  Po-Chang Hsu; Shyi-Jou Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.